General Information of the Protein
Protein ID
PT03142
Protein Name
Vascular endothelial growth factor A, long form
Secondarily
Protein Name
Vascular permeability factor
Gene Name
VEGFA
Secondarily
Gene Name
VEGF
Sequence
MTDRQTDTAPSPSYHLLPGRRRTVDAAASRGQGPEPAPGGGVEGVGARGVALKLFVQLLGCSRFGGAVVRAGEAEPSGAARSASSGREEPQPEEGEEEEEKEEERGPQWRLGARKPGSWTGEAAVCADSAPAARAPQALARASGRGGRVARRGAEESGPPHSPSRRGSASRAGPGRASETMNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Secreted protein
Function
Participates in the induction of key genes involved in the response to hypoxia and in the induction of angiogenesis such as HIF1A (PubMed:35455969). Involved in protecting cells from hypoxia-mediated cell death (By similarity).
    Show/Hide
Uniprot ID
Primary ID:
P15692

Secondarily ID:
B5BU86
H0Y2S8
H0Y407
H0Y414
H0Y462
H0Y8N2
H3BLW7
O60720
O75875
Q074Z4
Q16889
Q5UB46
Q6P0P5
Q96KJ0
Q96L82
Q96NW5
Q9H1W8
Q9H1W9
Q9UH58
Q9UL23
    Show/Hide
Ensembl ID
ENSG00000112715
HGNC ID
HGNC:12680
Subcellular Location
Cytoplasm
Nucleus
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Compound ID Compound Name Compound Formula
CP0099539
US11426393, Compound Table XV.17
   Show/Hide
C15H14ClN3O3
 1
1
EC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0064970
US11426393, Compound Table XV.16
   Show/Hide
C15H13ClN2O4
 1
1
EC50 = 3300 nM
   TI
   LI
   LO
   TS
CP0164653
US8598210, Table XV, 8
   Show/Hide
C15H11N3O4
 1
1
EC50 = 4300 nM
   TI
   LI
   LO
   TS
CP0060213
US11426393, Compound Table XV.11
   Show/Hide
C14H11ClN2O4
 1
1
EC50 = 7600 nM
   TI
   LI
   LO
   TS
CP0109269
US11426393, Compound Table XV.7
   Show/Hide
C15H13ClN2O4
 1
1
EC50 = 7700 nM
   TI
   LI
   LO
   TS
CP0148616
US11426393, Compound Table XV.6
   Show/Hide
C16H16N2O4
 1
1
EC50 = 8200 nM
   TI
   LI
   LO
   TS
CP0107872
US11426393, Compound Table XV.1
   Show/Hide
C15H13ClN2O4
 1
1
EC50 = 9900 nM
   TI
   LI
   LO
   TS
CP0076777
US11426393, Compound Table XV.13
   Show/Hide
C17H18N2O4
 1
1
EC50 = 15000 nM
   TI
   LI
   LO
   TS
CP0066265
US11426393, Compound Table XV.4
   Show/Hide
C15H14N2O4
 1
1
EC50 = 42100 nM
   TI
   LI
   LO
   TS
CP0226971
US11426393, Compound Table XV.21
   Show/Hide
C16H15N3O5
 1
1
EC50 = 50100 nM
   TI
   LI
   LO
   TS
CP0099562
US11426393, Compound Table XV.5
   Show/Hide
C16H15NO4
 1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0105696
US8598210, Table XV, 19
   Show/Hide
C16H14N6O4
 1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0122947
US8598210, Table XV, 24
   Show/Hide
C15H12N6O4
 1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0141223
US11426393, Compound Table XV.2
   Show/Hide
C15H13ClN2O4
 1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0199997
US11426393, Compound Table XV.14
   Show/Hide
C14H11FN2O4
 1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0257735
US8598210, Table XV, 20
   Show/Hide
C15H11N3O4
 1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0257737
US8598210, Table XV, 18
   Show/Hide
C16H13N3O4
 1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0261239
US8598210, Table XV, 3
   Show/Hide
C16H13N3O4
 1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0342923
US11426393, Compound Table XV.15
   Show/Hide
C17H18N2O5
 1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0369799
US11426393, Compound Table XV.23
   Show/Hide
C19H19N3O5
 1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0520375
US11426393, Compound Table XV.22
   Show/Hide
C20H21N3O5
 1
1
EC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0140226
US10562854, No. E33
   Show/Hide
C16H18N2O6S
 1
1
IC50 = 2100 nM
   TI
   LI
   LO
   TS
CP0242973
US10562854, No. F3
   Show/Hide
C12H10ClNO2
 1
1
IC50 = 7400 nM
   TI
   LI
   LO
   TS
CP0092311
US10562854, No. B9
   Show/Hide
C24H27N3O2
 1
1
IC50 = 12600 nM
   TI
   LI
   LO
   TS
CP0054156
US10562854, No. A41
   Show/Hide
C22H28ClN3O4
 1
1
IC50 = 16600 nM
   TI
   LI
   LO
   TS
CP0093595
US10562854, No. D14
   Show/Hide
C21H22ClN5O4S
 1
1
IC50 = 19000 nM
   TI
   LI
   LO
   TS
CP0093596
US10562854, No. C14
   Show/Hide
C21H22N2O2
 1
1
IC50 = 20600 nM
   TI
   LI
   LO
   TS
CP0170125
US10562854, No. D10
   Show/Hide
C23H31N3O4S
 1
1
IC50 = 27000 nM
   TI
   LI
   LO
   TS
CP0118342
US10562854, No. C17
   Show/Hide
C20H26N2O2
 1
1
IC50 = 27400 nM
   TI
   LI
   LO
   TS
CP0349695
US10562854, No. A18
   Show/Hide
C20H26N2O3
 1
1
IC50 = 29200 nM
   TI
   LI
   LO
   TS
CP0097787
US10562854, No. C1
   Show/Hide
C20H19ClN2O2
 1
1
IC50 = 42000 nM
   TI
   LI
   LO
   TS
CP0351548
US10562854, No. C35
   Show/Hide
C19H22N4O2
 1
1
IC50 = 42500 nM
   TI
   LI
   LO
   TS
CP0118343
US10562854, No. B5
   Show/Hide
C19H24N2O3
 1
1
IC50 = 53000 nM
   TI
   LI
   LO
   TS
CP0242971
US10562854, No. C33
   Show/Hide
C16H20N2O2S
 1
1
IC50 = 53000 nM
   TI
   LI
   LO
   TS
CP0173889
US10562854, No. C19
   Show/Hide
C19H23N3O3
 1
1
IC50 = 62900 nM
   TI
   LI
   LO
   TS
CP0351549
US10562854, No. B14
   Show/Hide
C21H22ClN5O2
 1
1
IC50 = 78000 nM
   TI
   LI
   LO
   TS
CP0097789
US10562854, No. F2
   Show/Hide
C12H10ClNO2
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0140226
US10562854, No. E33
   Show/Hide
C16H18N2O6S
 1
1 IC50 = 2100 nM
CP0242973
US10562854, No. F3
   Show/Hide
C12H10ClNO2
 1
1 IC50 = 7400 nM
CP0092311
US10562854, No. B9
   Show/Hide
C24H27N3O2
 1
1 IC50 = 12600 nM
CP0054156
US10562854, No. A41
   Show/Hide
C22H28ClN3O4
 1
1 IC50 = 16600 nM
CP0093595
US10562854, No. D14
   Show/Hide
C21H22ClN5O4S
 1
1 IC50 = 19000 nM
CP0093596
US10562854, No. C14
   Show/Hide
C21H22N2O2
 1
1 IC50 = 20600 nM
CP0170125
US10562854, No. D10
   Show/Hide
C23H31N3O4S
 1
1 IC50 = 27000 nM
CP0118342
US10562854, No. C17
   Show/Hide
C20H26N2O2
 1
1 IC50 = 27400 nM
CP0349695
US10562854, No. A18
   Show/Hide
C20H26N2O3
 1
1 IC50 = 29200 nM
CP0097787
US10562854, No. C1
   Show/Hide
C20H19ClN2O2
 1
1 IC50 = 42000 nM
CP0351548
US10562854, No. C35
   Show/Hide
C19H22N4O2
 1
1 IC50 = 42500 nM
CP0242971
US10562854, No. C33
   Show/Hide
C16H20N2O2S
 1
1 IC50 = 53000 nM
CP0173889
US10562854, No. C19
   Show/Hide
C19H23N3O3
 1
1 IC50 = 62900 nM
CP0351549
US10562854, No. B14
   Show/Hide
C21H22ClN5O2
 1
1 IC50 = 78000 nM
CP0097789
US10562854, No. F2
   Show/Hide
C12H10ClNO2
 1
1 IC50 > 100000 nM
Clinical Information about the Protein
Target 1 ( Vascular endothelial growth factor A (VEGFA) )
Target Type Successful Target
Disease 2 Target-related Diseases  2
1 Non-small-cell lung cancer [ICD-11: 2C25.Y]
2 Breast cancer [ICD-11: 2C60-2C65]
Clinical Trial Drug(s) 2 Clinical Trial Drugs  2
1 Avastin+/-Tarceva Phase 3
Non-small-cell lung cancer
2 Bevacizumab + Trastuzumab Phase 3
Breast cancer
Target 2 ( VEGF A165 messenger RNA (VEGF A165 mRNA) )
Target Type Literature-reported Target
Target 3 ( VEGF messenger RNA (VEGF mRNA) )
Target Type Literature-reported Target